Not all clients with CLL call for therapy. Even with all latest advancements, the iwCLL nevertheless suggests watchful observation for sufferers with asymptomatic ailment.86 This recommendation relies on no less than two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR)… Read More